Rasoya Protein consolidated Mar '15 sales at Rs 54.26 crore
Rasoya Proteins has reported a consolidated total income from operations of Rs 54.26 crore and a net loss of Rs 36.17 crore for the quarter ended Mar '15
June 02, 2015 / 02:12 PM IST
| Rasoya Proteins has reported a consolidated total income from operations of Rs 54.26 crore and a net loss of Rs 36.17 crore for the quarter ended Mar '15. | | For the quarter ended Mar 2014 the consolidated total income from operations was Rs 422.42 crore and net profit was Rs 17.55 crore. | | Rasoya Protein shares closed at 0.32 on June 01, 2015 (BSE) and has given -87.79% returns over the last 6 months and -98.08% over the last 12 months. |
|
| | Rasoya Proteins | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Mar '15 | Dec '14 | | | Mar '14 | | Net Sales/Income from operations | 52.99 | 177.85 | | | 413.99 | | Other Operating Income | 1.27 | 0.09 | | | 8.43 | | Total Income From Operations | 54.26 | 177.94 | | | 422.42 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 46.47 | 96.38 | | | 293.55 | | Purchase of Traded Goods | 30.53 | 37.31 | | | 54.90 | | Increase/Decrease in Stocks | -10.14 | 11.12 | | | 10.26 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 3.80 | 2.68 | | | 1.93 | | Depreciation | 3.98 | 2.75 | | | 2.67 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 6.80 | 9.95 | | | 41.29 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -27.18 | 17.74 | | | 17.82 | | Other Income | 2.44 | 0.09 | | | 5.67 | | P/L Before Int., Excpt. Items & Tax | -24.74 | 17.84 | | | 23.48 | | Interest | 15.98 | 14.39 | | | 11.22 | | P/L Before Exceptional Items & Tax | -40.72 | 3.45 | | | 12.27 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -40.72 | 3.45 | | | 12.27 | | Tax | -4.55 | -0.51 | | | -5.29 | | P/L After Tax from Ordinary Activities | -36.17 | 3.41 | | | 17.55 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -36.17 | 3.41 | | | 17.55 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -36.17 | 3.41 | | | 17.55 | | Equity Share Capital | 170.89 | 170.89 | | | 170.89 | | Reserves Excluding Revaluation Reserves | 150.81 | 150.81 | | | 150.81 | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -0.21 | 0.02 | | | 0.10 | | Diluted EPS | -0.21 | 0.02 | | | 0.10 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -0.21 | 0.02 | | | 0.10 | | Diluted EPS | -0.21 | 0.02 | | | 0.10 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 132.17 | 116.75 | | | 116.75 | | Share Holding (%) | 77.34 | 68.00 | | | 68.32 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 6.93 | 22.35 | | | 3.36 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 12.80 | 41.00 | | | 6.20 | | - Per. of shares (as a % of the total Share Cap. of the company) | 4.06 | 13.00 | | | 1.96 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 31.80 | 31.80 | | | 54.15 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 95.94 | 59.00 | | | 100.00 | | - Per. of shares (as a % of the total Share Cap. of the company) | 18.61 | 19.00 | | | 31.68 | | Source : Dion Global Solutions Limited |
|
US export curbs on COVID-19 vaccine ingredients limiting efforts to scale up production: Adar Poonawalla Watch more 
French IT firm Capgemini to cover vaccination costs of India employees, their dependents Watch more 
Women's Day Special: Byju's co-founder Divya Gokulnath on Moneycontrol Watch more 
Haryana’s 75% reservation law may disrupt post-COVID-19 recovery, say firms Watch more 
